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Abstract
One of the biggest challenges during the coronavirus disease 2019 (COVID-19) pandemic continues to be the
detection of asymptomatic and presymptomatic persons infected with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). Persons infected with SARS-CoV-2 who do not have symptoms of COVID-19
may transmit the virus to others and may have subclinical lung abnormalities. Some hospitals use SARS-
CoV-2 antigen tests for pre-admission screening testing because they are relatively inexpensive, have a rapid
turnaround time, and can be performed at the point of care; however, antigen tests are generally less
sensitive than nucleic acid amplification tests with reverse transcription polymerase chain reaction (RT-PCR)
assay. Moreover, as the local COVID-19 prevalence increases, the negative predictive value of antigen tests
may decrease, meaning that the probability of having false-negative results may increase. We present a case
of a patient who, prior to admission for a surgical procedure, had a negative antigen test result for SARS-
CoV-2, had no respiratory symptoms, and had no suspected or known exposure to SARS-CoV-2; however,
she tested positive for SARS-CoV-2 RNA after admission. The only factor that led the healthcare team to
suspect SARS-CoV-2 infection was an unexpected finding of bilateral ground-glass opacities on an
abdominopelvic computed tomography (CT), which was performed to assess the extent of a perianal abscess
the patient presented. This case highlights the importance of using highly sensitive SARS-CoV-2 tests for
pre-admission screening testing in the hospital setting.
Categories: Internal Medicine
Keywords: abdominopelvic computed tomography, admission, antigen tests, asymptomatic, covid-19, ground-glass
opacities, negative predictive value, sars-cov-2
Introduction
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), formerly known as 2019-nCoV, causes
the coronavirus disease 2019 (COVID-19), which at the end of 2019 started as a cluster of pneumonia cases
of unknown etiology in Wuhan, Hubei province, central China [1-3]. SARS-CoV-2 binds the angiotensin-
converting enzyme 2 (ACE2) host receptor and uses the host transmembrane protease serine 2 (TMPRSS2) for
cell entry [1,4]. Symptoms of COVID-19 include fever, cough, shortness of breath, myalgia, headache, sore
throat, diarrhea, nausea and vomiting, loss of smell or taste, and rhinorrhea [5]. A common pattern on chest
computed tomography (CT) of symptomatic patients is ground-glass opacity [6]. Nevertheless, there have
been reports of people infected with SARS-CoV-2 who did not develop symptoms of COVID-19, transmitted
the virus to others, and had incidental CT findings of ground-glass opacities [7]. Furthermore, many
institutions conduct screening testing using nucleic acid amplification testing (NAAT) with reverse-
transcription polymerase chain reaction (RT-PCR) assay for SARS-CoV-2 upon a patient’s admission to the
hospital, but other institutions conduct screening testing with antigen tests for SARS-CoV-2, which are
generally less sensitive than NAATs [8]. Here we report a case of a patient who did not present with
respiratory tract symptoms, was not suspected of having COVID-19, and tested negative for a SARS-CoV-2
antigen test upon admission for a surgical procedure; however, an abdominopelvic CT scan incidentally
revealed bilateral ground-glass opacities consistent with viral pneumonia.
Case Presentation
A 61-year-old woman was admitted to the hospital with fever, leukocytosis, and severe pain in the anal area.
The patient had been in her usual state of health until seven days before this admission, when perianal pain
developed. She was evaluated by her primary care physician, who found an erythematous area in her
perianal skin and prescribed her a course of oral clindamycin and an antibiotic cream. Seven days later, she
returned to her primary care physician because her pain worsened. Ketorolac and empiric ceftriaxone were
administered, and she was sent to the emergency department.
In the emergency department, the patient presented with severe perianal pain. She had a history of diabetes
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mellitus, hypertension, obesity, hypercholesterolemia, and hypothyroidism. Her medications included
telmisartan, dapagliflozin, exenatide, atorvastatin, and levothyroxine. Shortness of breath, cough, smell or
taste disturbances, and myalgia were not reported. No suspected or known exposure to SARS-CoV-2 was
reported. On examination, the temperature was 100.1°F, blood pressure 110/52 mmHg, heart rate was 85
beats per minute, respiratory rate was 19 breaths per minute, and the oxygen saturation was 100% while the
patient was breathing ambient air. The lungs were clear on auscultation. In the perianal area, there was an
abscess that had begun to drain spontaneously. The white cell count was 11,400/µL (reference range: 4,800-
10,900/µL), lactic acid was 2.32 mmol/L (reference range: 0.5-1.99 mmol/L), and anion gap was 14 mEq/L
(reference range: 2-12 mEq/L). A decision for admission of the patient was made; therefore, a SARS antigen
fluorescent immunoassay (FIA) screening test was performed, and the result was negative. Morphine and
acetaminophen were administered for pain and fever. The surgery department was consulted, and a
combination of vancomycin with piperacillin-tazobactam was recommended. In addition, a CT of the
abdomen and pelvis was performed after the administration of intravenous contrast material.
The abdominopelvic CT scan revealed a loculated fluid collection posterior to the anus consistent with an
abscess. In addition, there were peripheral ground-glass opacities in both imaged lung bases (Figure 1). Five
hours after the initial presentation, the patient was admitted. A nasopharyngeal swab was obtained for
NAAT. Six hours after admission, the test was positive for SARS-CoV-2 RNA and the patient was transferred
to the COVID-19 unit. A posteroanterior radiograph of the chest was performed, and the radiologist reported
slightly increased interstitial markings, especially in the lung bases. Ten hours later, incision and drainage of
the patient’s abscess were successfully performed in the operating room. The postoperative diagnoses
included horseshoe perirectal abscess, perianal abscess, and asymptomatic SARS-CoV-2 infection. No
specific therapy for COVID-19 was administered to the patient because she had no respiratory symptoms.
FIGURE 1: Bilateral peripheral ground-glass opacities in the lung bases
(arrows) of a 61-year-old woman, unexpectedly noted on axial
abdominopelvic CT performed to assess the extent of a perianal
abscess.
Three days after admission, a chest radiograph was performed, which did not reveal any abnormalities. The
next day, the patient continued without any respiratory symptoms, and the perianal pain had significantly
decreased. The vital signs were normal. The white cell count, the value of the serum anion gap, and the
serum lactate levels were normal. The patient was subsequently discharged home with a prescription of
levofloxacin. During her follow-up visit with the surgery department 36 days later, she did not report any
symptoms whatsoever.
Discussion
Early identification of asymptomatic (i.e., infected persons who will not develop symptoms) and
presymptomatic (i.e., infected persons who will eventually develop symptoms) SARS-CoV-2 infections
continues to be a challenge, even more so when these patients do not have known or suspected exposure to
SARS-CoV-2. In a report released by the United States Centers for Disease Control and Prevention (CDC),
among 373,883 laboratory-confirmed COVID-19 cases with data on individual symptoms, 70% reported
fever, cough, or shortness of breath, 36% reported myalgia, and 34% reported headache; in addition, sore
2020 Soler-Luna et al. Cureus 12(10): e11044. DOI 10.7759/cureus.11044 2 of 4
throat, diarrhea, nausea and vomiting, loss of smell or taste, and rhinorrhea were significantly reported [5].
In one study of 1,099 patients with laboratory-confirmed COVID-19 from Wuhan and other areas in China,
ground-glass opacity was the most common radiologic finding on chest CT of symptomatic patients upon
admission [6]. On the other hand, the proportion of infections with SARS-CoV-2 that are asymptomatic and
presymptomatic is not known. A narrative review analyzed three cohorts with representative samples and
estimated the asymptomatic infection rate as high as 40% to 45%, with a conservative estimate of 30% or
higher to account for the presymptomatic infections that were not quantified; however, prospective studies
with large and representative samples of the general population need to be conducted so as to better reflect
the population at large [7]. Although our patient presented with fever in the emergency department, which
is a common symptom of COVID-19, we can assume that she was a case of asymptomatic SARS-CoV-2
infection because all her symptoms were very consistent with her abscesses.
Pre-admission screening testing for SARS-CoV-2 is intended to identify infected persons who are
asymptomatic or presymptomatic without known or suspected exposure to SARS-CoV-2 so that infection
control interventions can be taken to prevent further transmission [9]. For pre-admission screening testing,
NAAT with RT-PCR to detect SARS-CoV-2 RNA is preferred over antigen testing (i.e., tests that detect SARS-
CoV-2 antigen) because it is generally more sensitive (i.e., it has fewer false-negative results); however,
some hospitals use antigen tests because they are relatively inexpensive, have a faster time to results
compared to some NAATs, and can be performed at the point of care [8]. Furthermore, there are limited data
to guide the use of rapid antigen tests as screening tests in asymptomatic and presymptomatic persons to
detect or exclude SARS-CoV-2 infection [8]. Our patient tested negative for a SARS antigen FIA test as part
of the pre-admission screening policy of the hospital, which was a false-negative result because she tested
positive for an RT-PCR test thereafter, with a time interval between collection of samples for the two tests of
about 8 hours as per CDC guidelines.
As of September 18, 2020, the U.S. Food and Drug Administration (FDA) has granted emergency use
authorizations (EUAs) to four SARS-CoV-2 antigen tests [10]. Antigen levels in specimens collected beyond
five to seven days of the onset of symptoms may drop below the limit of detection of these tests [8]. The
negative predictive value (NPV) of these tests is the probability that a patient who has a negative test result
truly does not have SARS-CoV-2 infection [8]. The NPV may vary depending on the test sensitivity and the
pretest probability (i.e., an estimate, before testing, of the person’s chance of being infected), which, in turn,
might depend on local COVID-19 prevalence, SARS-CoV-2 exposure history, and symptoms [11]. For
instance, assume that the local COVID-19 prevalence equals the pretest probability and the test specificity is
100%; if the local COVID-19 prevalence were 20% and the sensitivity 95%, the NPV would be 99% (1% of
negative test results would be false negative); however, with a prevalence of 50% and a sensitivity of 70%,
the NPV would be 77% (23% of negative test results would be false negative) [11]. This means that as the
local prevalence of COVID-19 increases and tests with lower sensitivity than NAATs (e.g., antigen tests) are
used, the probability of having false-negative results may increase even with a test specificity of 100%,
which highlights the importance of using highly sensitive SARS-CoV-2 tests for pre-admission screening.
Several studies have reported ground-glass opacities as one of the most common CT findings in
asymptomatic persons infected with SARS-CoV-2 [12,13]. Nonetheless, data on CT findings in asymptomatic
persons infected with SARS-CoV-2 are limited. One important limitation is the lack of longitudinal data
collection over a sufficiently long time to distinguish between asymptomatic and presymptomatic cases [7].
An abdominopelvic CT was performed on our patient to assess the extent of her perianal abscess, which
unexpectedly showed bilateral ground-glass opacities in the lung bases, consistent with viral pneumonia.
The fact that an incidental abdominopelvic CT scan finding of bilateral ground-glass opacities was the only
factor that prompted our team to suspect SARS-CoV-2 infection demonstrates how challenging it is to
detect asymptomatic and presymptomatic infections in the healthcare setting and how it is possible to have
SARS-CoV-2 asymptomatic infections with subclinical lung abnormalities. When pre-admission or pre-
procedure screening tests fail to detect asymptomatic or presymptomatic patients in the hospital setting, it
creates a false sense of security to the patient and the healthcare team caring for the patient, prevents
infected patients from being isolated or housed with other similarly infected patients, and increases the risk
of infection among vulnerable patients.
Conclusions
The amount of testing for SARS-CoV-2 must be increased for patients without symptoms of COVID-19 in
the general population, even without known or suspected exposure to SARS-CoV-2, due to the likely high
proportion of asymptomatic and presymptomatic infected persons transmitting the virus to others.
Furthermore, asymptomatic and presymptomatic persons may have subclinical lung abnormalities, as
detected by CT as ground-glass opacities. On the other hand, the healthcare team should perform pre-
admission screening testing for SARS-CoV-2 with tests that have higher sensitivity than antigen tests (e.g.,
NAAT with RT-PCR) and short turnaround time at the point of care. If resources do not allow these practices
and antigen tests are used, a negative antigen test result should be considered presumptive based on its
lower NPV in the context of high local prevalence of COVID-19; this may also be considered even in places
with low reported prevalence due to the unknown proportion of asymptomatic infections.
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